Log in
NASDAQ:VNDA

Vanda Pharmaceuticals SEC Filings & 10K Form

$9.85
-0.08 (-0.81 %)
(As of 09/19/2020 12:08 AM ET)
Add
Compare
Today's Range
$9.50
Now: $9.85
$10.07
50-Day Range
$9.55
MA: $10.65
$12.00
52-Week Range
$7.12
Now: $9.85
$17.85
Volume1.31 million shs
Average Volume695,501 shs
Market Capitalization$538.31 million
P/E Ratio4.71
Dividend YieldN/A
Beta0.47

SEC Filings

Vanda Pharmaceuticals (NASDAQ:VNDA) SEC Filings

DateFilerForm TypeView
08/21/2020
5:08 PM
Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2020
4:18 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2020
3:42 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2020
3:39 PM
Jones Aranthan II (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2020
6:01 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2020
7:19 PM
Moran Kevin Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2020
7:17 PM
Jones Aranthan II (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:13 PM
Vanda Pharmaceuticals (Issuer)
Watkins Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:12 PM
Vanda Pharmaceuticals (Issuer)
Ward Anne Sempowski (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:11 PM
Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:11 PM
DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2020
6:10 PM
Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
4:16 PM
Vanda Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/02/2020
3:13 PM
Vanda Pharmaceuticals (Issuer)
Watkins Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
6:13 AM
Vanda Pharmaceuticals (Filer)
Form DEFA14A
05/26/2020
6:11 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
6:43 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2020
6:01 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/24/2020
3:40 PM
Vanda Pharmaceuticals (Filer)
Form CT ORDER
04/22/2020
3:06 PM
Vanda Pharmaceuticals (Filer)
Form DEFA14A
04/22/2020
3:05 PM
Vanda Pharmaceuticals (Filer)
Form DEF 14A
03/13/2020
4:17 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2020
3:30 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2020
5:05 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
5:04 PM
Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
5:03 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
5:02 PM
Jones Aranthan II (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2020
5:01 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2020
7:54 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2020
6:02 AM
Vanda Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2020
3:20 PM
Mitchell Stephen Ray (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2020
5:12 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
2:16 PM
Palo Alto Investors LP (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2020
10:10 AM
ARMISTICE CAPITAL, LLC (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2020
3:38 PM
MACQUARIE GROUP LTD (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/12/2020
12:48 PM
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G
02/04/2020
11:30 AM
BlackRock Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/03/2020
5:15 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2020
3:08 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
4:19 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
4:26 PM
Reverberi Gian Piero (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
4:26 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
4:25 PM
Kelly James Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2020
4:25 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:21 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2019
6:03 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/28/2019
8:47 PM
Vanda Pharmaceuticals (Issuer)
Ward Anne Sempowski (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
8:46 PM
Vanda Pharmaceuticals (Issuer)
Ward Anne Sempowski (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/28/2019
3:55 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/28/2019
3:30 PM
DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:52 PM
Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:48 PM
Vanda Pharmaceuticals (Issuer)
Wijkstrom Joakim (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/21/2019
3:46 PM
Jones Aranthan II (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/19/2019
6:09 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2019
3:58 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
6:04 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/31/2019
3:05 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2019
7:35 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/16/2019
4:25 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
3:58 PM
ARMISTICE CAPITAL, LLC (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G
06/17/2019
4:03 PM
Vanda Pharmaceuticals (Issuer)
Watkins Thomas (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:03 PM
DUGAN RICHARD W (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:02 PM
COLA MICHAEL F (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2019
4:01 PM
Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:32 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
3:32 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2019
4:02 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2019
3:32 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
6:02 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/30/2019
7:30 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
3:31 PM
Vanda Pharmaceuticals (Filer)
Form DEF 14A
04/24/2019
4:34 PM
Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/24/2019
4:31 PM
Chrousos Phaedra (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/24/2019
3:36 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
4:06 PM
Kelly James Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2019
4:02 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
3:27 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
3:19 PM
Kelly James Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
3:18 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
7:30 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2019
6:02 AM
Vanda Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2019
1:59 PM
ARMISTICE CAPITAL, LLC (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2019
1:51 PM
MACQUARIE GROUP LTD (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2019
6:51 AM
Consonance Capital Management LP (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G
02/11/2019
9:31 AM
Vanda Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/06/2019
5:07 AM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2019
3:34 PM
Birznieks Gunther (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:33 PM
Kelly James Patrick (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
3:31 PM
Polymeropoulos Mihael Hristos (Reporting)
Vanda Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2018
3:31 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2018
3:32 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
4:08 PM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
3:06 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2018
3:26 PM
BlackRock Inc. (Filed by)
Vanda Pharmaceuticals (Subject)
Form SC 13G/A
10/04/2018
3:31 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
4:24 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
4:06 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2018
4:00 PM
Vanda Pharmaceuticals (Issuer)
Williams Timothy (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/02/2018
6:01 AM
Vanda Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2018
3:19 PM
Vanda Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.